C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding C4 Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 117 | 121 | +4 |
| Shares | 39.2M | 37.4M | −1.83M (−4.7%) |
| Value | $231.4M | $117.5M | −$113.9M (−49.2%) |
New holders (21)
Institutions that held C4 Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TCG Crossover Management, LLC | 1,250,000 | $3.92M | 0.77% |
| Millennium Management LLC | 153,556 | $482.0K | 0.00% |
| HRT Financial LP | 119,612 | $375.0K | 0.00% |
| Marshall Wace, LLP | 113,236 | $355.6K | 0.00% |
| Panagora Asset Management Inc | 107,891 | $338.8K | 0.00% |
| Jane Street Group, LLC | 100,741 | $316.3K | 0.00% |
| Ergoteles LLC | 79,770 | $250.5K | 0.01% |
| Man Group plc | – | $126.0K | 0.00% |
| Caxton Associates LP | 38,925 | $122.2K | 0.02% |
| Y-Intercept (Hong Kong) Ltd | 31,362 | $98.5K | 0.01% |
| Qube Research & Technologies Ltd | 29,688 | $93.2K | 0.00% |
| Tudor Investment Corp Et Al | 23,966 | $75.0K | 0.00% |
| Point72 Asset Management, L.P. | 23,733 | $74.5K | 0.00% |
| B. Metzler seel. Sohn & Co. AG | 18,120 | $56.9K | 0.00% |
| Centiva Capital, LP | 16,549 | $52.0K | 0.00% |
| Captrust Financial Advisors | 15,342 | $48.2K | 0.00% |
| Dynamic Technology Lab Private Ltd | 12,179 | $38.0K | 0.00% |
| ExodusPoint Capital Management, LP | 10,551 | $33.0K | 0.00% |
| Verition Fund Management LLC | 10,188 | $32.0K | 0.00% |
| Wells Fargo & Company | 7,487 | $23.5K | 0.00% |
| Dark Forest Capital Management LP | 134 | $421 | 0.00% |
Sold out (17)
Institutions that held C4 Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| RTW Investments, LP | 2,819,472 | $16.6M |
| Driehaus Capital Management LLC | 345,969 | $2.04M |
| Rafferty Asset Management, LLC | 177,858 | $1.05M |
| Jump Financial, LLC | 36,000 | $212.4K |
| Alpine Global Management, LLC | 18,574 | $110.0K |
| Aquatic Capital Management LLC | 13,800 | $80.0K |
| Rockefeller Capital Management L.P. | 11,859 | $69.0K |
| Corton Capital Inc. | 10,526 | $62.1K |
| Occudo Quantitative Strategies LP | 10,379 | $61.2K |
| Lazard Asset Management LLC | 4,685 | $27.0K |
| The PNC Financial Services Group, Inc. | 2,000 | $11.8K |
| Allspring Global Investments Holdings, LLC | 725 | $4.28K |
| Advisor Group Holdings, Inc. | 185 | $1.00K |
| Steward Partners Investment Advisory, LLC | 100 | $590 |
| Accurate Wealth Management, LLC | 31 | $245 |
| Lindbrook Capital, LLC | 31 | $183 |
| Simplex Trading, LLC | 44 | $0 |